Founded in 2007, the fund focuses on financially promising products and technologies in life sciences, including pharmaceuticals, biotechnology, and medical devices. It prefers to invest in start-ups in the financial services, e-commerce, marketplaces, and healthcare sectors. With a portfolio that includes companies like arGEN-X and Cavadis, the fund typically invests in rounds with multiple participants and has a track record of exits.